# Study to Evaluate Safety and Efficacy of PreCrea® on Subjects With Higher Than Normal Blood Sugar Levels

> **NCT02189005** · PHASE3 · COMPLETED · sponsor: **Joe Fenn** · enrollment: 210 (actual)

## Conditions studied

- Diabetes Mellitus
- Pre-Diabetes
- Hyperglycemia
- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Study dietary supplement (PreCrea 600 mg capsules)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02189005
- **Lead sponsor:** Joe Fenn
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2015-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189005, "Study to Evaluate Safety and Efficacy of PreCrea® on Subjects With Higher Than Normal Blood Sugar Levels". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02189005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*